AlphAIAlphAI — Financial news for AI agents
tradingview.com$SVIA

Silvia 3Q 2026: Revenue $135K, EPS $1.3 — 10-Q Summary

Silvia reported 3Q 2026 revenue of $135K, up 75% YoY, and net income of $122.85M, up 62% YoY. The increase was driven by a $137.2M unrealized gain on digital assets, mainly Bitcoin. Operating costs rose, and the company launched new AI products and a SPV Fund. Silvia held 5,035 Bitcoin worth $420.7M at quarter-end.

Original reporting
tradingview.com
Published Nov 13, 2026, 10:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 10:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Silvia 3Q 2026: Revenue $135K, EPS $1.3 — 10-Q Summary — source image
Source · tradingview.com
Decision brief

The 30-second read

$SVIANeutralLow
01

Why it matters

The 10‑Q reveals a dramatic swing in net income due to crypto price movements, while operating revenue remains negligible, suggesting volatility risk.

02

Market read

The filing provides the first public earnings data for SVIA, with a notable crypto‑driven earnings swing but limited operational growth.

03

What to watch

Potential regulatory scrutiny of crypto holdings and the sustainability of AI product launches.

Relevance 5/10Novelty 8/10Timing: post‑filing today

Background

Silvia Inc. is a micro‑cap AI‑focused fintech that recently acquired an AI platform and holds a sizable Bitcoin position.

Company-level read

Ticker impact

$SVIANeutralMedium confidence
Context

Silvia Inc. filed its 10‑Q reporting Q3 2026 revenue of $135K and net income of $122.85M, driven by a $137.2M unrealized Bitcoin gain.

Expected impact

limited upside as the Bitcoin gain may boost sentiment, but low operating revenue caps broader rally.

Evidence & confidence

The primary news is the 10‑Q filing; the Bitcoin exposure creates short‑term price pressure, yet the company’s tiny revenue base suggests modest long‑term impact.

Market effects

Sector

Highlights crypto exposure risk for small cap tech firms.

Regional

Primarily U.S. micro‑cap market; no broader regional effect.

Global

Minimal; reflects Bitcoin price influence on niche issuers.

Counterpoint

What could challenge this read

Investors may view the Bitcoin gain as a one‑off boost and remain skeptical of sustainable growth.

Key entities

  • company
    Silvia Inc.

    Micro‑cap AI fintech with significant Bitcoin holdings.

Read at source← All news

Related articles

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

finance.yahoo.com
$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

finance.yahoo.com
$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

finance.yahoo.com
$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.

finance.yahoo.com
$YTRAMed

Yatra Online Inc (YTRA) (Q2 2027) Earnings Call Highlights: Air and Corporate Travel

Yatra Online (YTRA) reported Q2 2027 revenue from operations down 39% YoY to INR2,136M (~$22M) due to lower MICE volumes. Gross margin stayed flat at INR1,255M (~$13M). Adjusted EBITDA swung to negative INR32M (~negative $0.3M). CEO Gupta noted MICE recovery signs, TravelPro and Recap initiatives progress, and AI efficiency gains. Standalone hotels grew 20% YoY. H1 FY27 revenue declined 28% YoY to INR4,015M (~$42M).

finance.yahoo.com
$PARKHighAI 8/10

Park Dental Partners Inc (PARK) (Q3 2026) Earnings Call Highlights: Revenue Climbs 6%

Park Dental Partners Inc (PARK) reported Q3 2026 revenue of $64.9M, up 6% YoY, driven by acquisitions and clinical hours. The company acquired Village Family Dental for $39.1M, funded with cash, a small credit line draw, and stock. PARK updated its 2026 revenue outlook to $262M-$265M and adjusted EBITDA to $21.2M-$22.2M. Gross margin declined due to higher salaries and cybersecurity costs. The acquisition adds 47 doctors and expands PARK's footprint to North Carolina.

finance.yahoo.com